Briefly, different diluted antisera (anti-IDE and anti-SVA pig sera) and normal guinea pig serum as controls were used in IBRS-2 cells to perform the neutralization test. Fifty microliters of the antiserum treated at 56°C for 30 min was serially diluted 2-fold from 1:4 to 1:512. Then, the diluted antisera were mixed with SVA strain CH-FJ-2017 (200 TCID
50) and incubated for 1 h at 37°C in a 96-well plate. Subsequently, 100 μL of the mixtures was transferred to IBRS-2 cells in a 96-well plate and incubated for 1 h at 37°C. The cell supernatant was discarded, and after three washes, DMEM containing 2% FBS was added. After incubation for 48 h,
CCK-8 solution (APExBIO, USA) was added to the cells, and cell viability was detected according to the instructions of the CCK-8 assay kit. The percent protection from CPE was measured as described by Li et al. (49 (
link)) with minor modifications. The protection from CPE (%) was calculated as follows: 100 × (OD 450 of each serum – OD 450 of PC)/(OD 450 of cell control – OD 450 of PC), with Positive control (PC) representing a virus infection control. Each serum sample was assayed in triplicate, and the data are presented as the average value of triplicate results.
Ru Y., Hao R., Wu C., Li Y., Lu B., Liu H., Tian H., Li D., Shi Z., Luo J., Ma K., Zhang G., Liu X, & Zheng H. (2023). Identification of Potential Novel B-Cell Epitopes of Capsid Protein VP2 in Senecavirus A. Microbiology Spectrum, 11(4), e04472-22.